GPC6 and ovarian cancer: To investigate whether GPC6 and TMEM132D expression correlates with CD8+ T-lymphocyte infiltration in early stage ovarian cancer, we used qPCR to quantify the mRNA levels of the CD8A marker in the same cohort of patients.